Induction of megamitochondria by some chemicals inducing oxidative stress in primary cultured rat hepatocytes.
Effects of hydrazine, hydrogen peroxide and bromobenzene, inducers of free radicals, and those of erythromycin and cycloheximide, inhibitors of protein synthesis on structural changes of mitochondria in primary monolayer culture of rat hepatocytes were examined using laser confocal microscope and electron microscope. After 22 h of incubation of hepatocytes with 0.2 mM hydrogen peroxide or 10 microg ml-1 of erythromycin, mitochondria became extremely enlarged. Mitochondria of hepatocytes isolated from control rats became slightly to moderately enlarged in the presence of 2 mM hydrazine, while those of hepatocytes isolated from phenobarbital-pretreated animals became extremely enlarged in the presence of 2 mM hydrazine. Cycloheximide (0.5-10.0 microg ml-1) and bromobenzene (0.1-1.0 mM) failed to induce structural changes of mitochondria. The level of cytochrome P-450 in freshly prepared hepatocytes from phenobarbital-treated rats was 2.5 times higher than that from the control rats, and remained about three times higher than the latter after 22 h of incubation with 2 mM hydrazine. The level of malondialdehyde was invariably elevated when megamitochondria were induced. These results may suggest that oxidative stress is intimately related to the mechanism of the formation of megamitochondria and that the inhibition of cytoplasmic protein synthesis seems not to contribute the phenomenon. However, the detailed mechanism by which free radicals may induce megamitochondria remains to be elucidated.
Karbowski
M
M
Department of Cell Biology and Molecular Pathology, Nagoya University School of Medicine, Japan.
Kurono
C
C
Nishizawa
Y
Y
Horie
Y
Y
Soji
T
T
Wakabayashi
T
T
D000818:Animals; D001969:Bromobenzenes / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004917:Erythromycin / Q000494:pharmacology; D005609:Free Radicals / Q000378:metabolism; D006834:Hydrazines / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000494:pharmacology; D008054:Lipid Peroxides / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000648:ultrastructure; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D008930:Mitochondria, Liver / Q000187:drug effects / Q000648:ultrastructure*; D018384:Oxidative Stress; D010634:Phenobarbital / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D001969:Bromobenzenes; D005609:Free Radicals; D006834:Hydrazines; D008054:Lipid Peroxides; D011500:Protein Synthesis Inhibitors; C029424:hydrazine; D008315:Malondialdehyde; D004917:Erythromycin; D003577:Cytochrome P-450 Enzyme System; D003513:Cycloheximide; D006861:Hydrogen Peroxide; C032036:bromobenzene; D010634:Phenobarbital